[go: up one dir, main page]

Longnecker et al., 1996 - Google Patents

Regulation of Epstein—Barr virus latency by latent membrane protein 2

Longnecker et al., 1996

Document ID
18176311850260212034
Author
Longnecker R
Miller C
Publication year
Publication venue
Trends in microbiology

External Links

Snippet

Like other herpesviruses, Epstein—Barr virus persists in its host through its ability to establish a latent infection that periodically reactivates. Latent membrane protein 2A (LMP2A) regulates reactivation from latency by interfering with normal B cell signal …
Continue reading at www.cell.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
    • C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Similar Documents

Publication Publication Date Title
Longnecker et al. Regulation of Epstein—Barr virus latency by latent membrane protein 2
Longnecker Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
Hayajneh et al. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains
Thorley-Lawson Epstein-Barr virus: exploiting the immune system
Damania Oncogenic γ-herpesviruses: comparison of viral proteins involved in tumorigenesis
Dirmeier et al. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus
Ganem KSHV infection and the pathogenesis of Kaposi's sarcoma
Shigeta et al. Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus
Moore et al. Molecular virology of Kaposi's sarcoma–associated herpesvirus
Zacny et al. Inhibition of Epstein-Barr virus replication by a benzimidazole l-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-β-l-ribofuranosyl-1H-benzimidazole
Chen et al. The Epstein–Barr virus latency Bam HI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of Bam HI-Q promoter activity
Wick et al. IL-4 induces serine phosphorylation of the STAT6 transactivation domain in B lymphocytes
Hollyoake et al. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus
Zwezdaryk et al. Regulation of Wnt/β-catenin signaling by herpesviruses
Longnecker et al. WW-and SH3-domain interactions with Epstein-Barr virus LMP2A
Zhang et al. Multiple signal transducers and activators of transcription are induced by EBV LMP-1
Kato et al. Phosphorylation of a herpes simplex virus 1 dUTPase by a viral protein kinase, Us3, dictates viral pathogenicity in the central nervous system but not at the periphery
Direkze et al. Regulation of growth signalling and cell cycle by Kaposi's sarcoma‐associated herpesvirus genes
Jiang et al. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus
Zhang et al. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation
Damania et al. Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus
Cuomo et al. Upregulation of Epstein‐Barr virus‐encoded latent membrane protein by human herpesvirus 6 superinfection of EBV‐carrying Burkitt lymphoma cells
Kondo et al. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line
Altiok et al. Effect of transforming growth factor-beta 1 and-beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines
Kienzle et al. Induction of pleckstrin by the Epstein–Barr virus nuclear antigen 3 family